Ticker ALEC – Alector – sales, description, marketcap – Tickerday.com

ALEC

Alector

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 855.64M; Volume: 1.02M; AvgVol 3m: 950.35K; Beta: ;

Cost estimate:

P/E: ; EPS: -2.03; EPS growth quarter/prev quarter: -58.50%;

EPS growth this year: -125.00%; EPS growth past 5 years: ;

EPS ttm: -2.03;

P/S: 43.48; P/B: 2.27; P/Cashflow: 1.64; P/FCF: ;

Sales: 19.04M; Sales growth quarter/prev quarter: -53.60%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -28.60%; ROE – return on equity: -50.90%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 1.00%; Insider Transactions:-39.81%;

Institutional Ownership: 79.60%; Institutional Transactions: 2.82%;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *